© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

BNG refreshes euro presence with first deal in 2026

◆ Dutch issuer brings new euro benchmark at last, with social label ◆ Most recent euro line opened over 10 months ago ◆ Peers' bonds helpful to pricing given BNG's absence
SSA
BNG deal 'most exciting' while Eurofima will test long-dated demand

ABN Amro 'deliberately' enhances EuGB senior to meet FIG green bond shortage

There's been a lack of ESG labelled FIG issuance in March, despite this year's volume being higher than last year

GlobalCapital Bond Awards 2026: Voting now open

Have the chance to put forward your opinion and shape this year’s Bond Awards winners.
SSA
BNG deal 'most exciting' while Eurofima will test long-dated demand
Sub-sections
  • SK Bioscience has priced its IPO at the top of the marketed range, raising W1.49tr ($1.32bn) from South Korea’s largest listing in four years.
  • Colombia has increased its external funding programme for the year to over $10bn after forecasting a larger 2021 fiscal deficit than it recorded in 2020, exacerbating concerns about the government’s ability to maintain its investment grade credit rating.
  • SSA
    Pablo de Ramón-Laca is director general of the treasury and financial policy at Spain's Ministry of Economic Affairs and Digital Transformation. That places him in charge of the world's ninth largest sovereign debt stock, according to S&P data, for a country pummelled by the Covid-19 pandemic. Spain has the second highest number of cases in the EU and the seventh highest in the world. But even that is not the full story of the pandemic's impact.